Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1‐mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma
暂无分享,去创建一个
Haiyang Xie | Jinjun Li | Chao Ge | M. Yao | F. Zhao | G. Jiang | Hong Li | Tao-yang Chen | Hua Tian | H. Hou | Ying Cui | Ying Cui
[1] Rui Li,et al. Slug promoted vasculogenic mimicry in hepatocellular carcinoma , 2013, Journal of cellular and molecular medicine.
[2] Xi-jun Wang,et al. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma , 2013, Hepatology.
[3] G. Berx,et al. Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.
[4] Boping Zhou,et al. Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma , 2012, Nature Genetics.
[5] H. You,et al. MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2 , 2012, Cell cycle.
[6] R. Ballotti,et al. The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion , 2012, PloS one.
[7] Y. Yen,et al. Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer. , 2011, Anticancer research.
[8] Ming Yao,et al. Hypoxia‐inducible factor 1 alpha–activated angiopoietin‐like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule‐1/integrin β1 signaling in human hepatocellular carcinoma , 2011, Hepatology.
[9] G. K. Chu,et al. Loss of phosphatase and tensin homolog enhances cell invasion and migration through aKT/Sp‐1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance , 2011, Hepatology.
[10] Lijun Xue,et al. Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer. , 2011, Cancer research.
[11] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[12] Karen H. Vousden,et al. p53 and its mutants in tumor cell migration and invasion , 2011, The Journal of cell biology.
[13] Y. Yen,et al. p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest , 2011, Molecular Cancer Therapeutics.
[14] Lucila Ohno-Machado,et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. , 2011, Cancer research.
[15] M. Fukayama,et al. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro. , 2010, Human pathology.
[16] Wei Gao,et al. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines. , 2010, World journal of gastroenterology.
[17] D. Gillespie,et al. Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2 , 2010, The Journal of cell biology.
[18] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[19] D. Calvisi,et al. NORE1A tumor suppressor candidate modulates p21CIP1 via p53. , 2009, Cancer research.
[20] H. You,et al. Ribonucleotide reductase small subunit p53R2 suppresses MEK–ERK activity by binding to ERK kinase 2 , 2009, Oncogene.
[21] S. Sheng,et al. Metastasis and AKT activation , 2008, Cell cycle.
[22] Robert A. Weinberg,et al. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.
[23] Anti-cancer Effects of JKA97 Are Associated with Its Induction of Cell Apoptosis via a Bax-dependent and p53-independent Pathway* , 2008, Journal of Biological Chemistry.
[24] A. Rajasekaran,et al. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. , 2006, Cancer research.
[25] S. Natsugoe,et al. Expression of p53R2 Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma , 2006, Clinical Cancer Research.
[26] Alfonso Bellacosa,et al. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.
[27] K. Berns,et al. Akt and 14-3-3η regulate Miz1 to control cell-cycle arrest after DNA damage , 2005, Nature Cell Biology.
[28] S. Ashley,et al. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine , 2004, Oncogene.
[29] E. Okamoto,et al. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel , 1996, Clinical & Experimental Metastasis.
[30] Lijun Xue,et al. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53. , 2003, Cancer research.
[31] Yusuke Nakamura,et al. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools , 2003, Nature Genetics.
[32] K. Sugimachi,et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] S. Chi,et al. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma , 2002, International journal of cancer.
[34] E. Fearon,et al. The SLUG zinc-finger protein represses E-cadherin in breast cancer. , 2002, Cancer research.
[35] T. Mustelin,et al. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling , 2001, Nature Cell Biology.
[36] Yusuke Nakamura,et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage , 2000, Nature.
[37] Kenneth M. Yamada,et al. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. , 1999, Cancer research.
[38] U. Thorgeirsson,et al. Morphological study of vascular dissemination in a metastatic hepatocellular carcinoma model in the monkey , 1997, Hepatology.
[39] S. Hirohashi,et al. E‐cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma , 1996, Hepatology.